We select, stabilize, and register cannabis and hemp varieties with specific cannabinoid and terpene profiles for both medicinal and industrial use. We participate in local adaptation trials and work with national and international breeders to generate new genetics that can be registered with INASE and ARICCAME.

We implement guidelines to comply with best practices in every process, from the nursery and plant biomass production to harvesting, processing, and manufacturing. We use traceability and quality control methods for research and development of derived products for health and industrial use.

We study various methods and develop standardized processes for extraction and post-processing of flowers, and we formulate resins to ensure safety and efficacy.

We work on creating formulations tailored to different pathologies and administration methods. We test different concentrations and combinations of cannabinoids in inflorescences, oils, and resins.

Biocann promotes observational studies in conjunction with healthcare professionals and centers, with informed consent and ethical approval, to generate evidence on the responsible use of medical cannabis in patients who access treatment in accordance with current regulations.

We implement follow-up protocols to evaluate therapeutic outcomes, adjust doses, and improve product profiles. This evidence informs future lines of research.